相关实验视频

Updated: May 5, 2026

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

对RANK-RANKL结合的可视化和定量化,用于疾病调查和药物发现

Ken-Ichi Nakahama¹, Shiho Hidaka², Kanako Goto¹

¹Department of Cellular Physiological Chemistry, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.

|March 27, 2025

概括

研究人员开发了一种NanoLuc试验,用于实时检测结合NFκB (RANK) 和RANK连接体 (RANKL) 的受体激活器. 这种方法有助于理解骨质细胞贫乏性骨质疏松症和查骨质疏松症治疗方法.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
骨生物学骨生物学骨生物学

背景情况:

NFκB (RANK) 的受体激活剂及其连接体 (RANKL) 的结合对于骨质细胞分化和骨重塑至关重要.
骨的再吸收和形成失衡会导致像骨质疏松症这样的骨疾病.
了解RANK-RANKL相互作用对于开发治疗骨疾病至关重要.

研究的目的:

使用NanoLuc技术开发RANK-RANKL结合的实时检测方法.
调查特定的RANK和RANKL突变在自身逆性骨质疏松症 (ARO) 中的作用.
为了验证该试验在选抑制RANK-RANKL相互作用的化合物的实用性.

主要方法:

大BiT-RANK和RANKL-小BiT融合蛋白在HeLa细胞中的同时表达.
在RANK-RANKL结合时实时检测化学发光.
利用中和抗体和局部定向突变发生来确认结合特异性.
使用核因子kappa B记者基因测定来评估信号传导.

主要成果:

纳米Luc试验成功检测并量化了活细胞中的RANK-RANKL结合.
在RANK或RANKL中发生的突变与ARO废除光发和骨质结晶发生障碍有关.
试验表明抗RANKL抗体的抑制,证实了特异性.
在RANK (G54R) 突变体中观察到信号传导受损.

结论:

纳米Luc方法为实时RANK-RANKL结合检测提供了一个强大的工具.
由于特定突变而导致RANK-RANKL结合的损失是骨质细胞贫乏的ARO的一个关键因素.
这种测定对于ARO的机制研究和选抗骨质疏松症候选药物非常有价值.

关键词:

ARO (自身遗传性衰退性骨质疏松症) 是一种疾病.纳米Luc二进制技术的二进制技术 PPI (蛋白质与蛋白质的相互作用)兰克 (NFκB的受体激活剂)RANKL (NFκB连接体的受体激活器)

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Protein-Drug Binding: Determination Methods

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...